| Company | Total Oppositions |
|---|---|
| STRAWMAN LIMITED | 33 |
| JAMES POOLE LIMITED | 25 |
| MARGARET DIXON LIMITED | 19 |
| PATENT BOUTIQUE LLP | 13 |
| MAIWALD GMBH | 13 |
| DR. H. ULRICH DORRIES | 11 |
| BOULT WADE TENNANT LLP | 11 |
| HOFFMANN EITLE | 10 |
| PFIZER INC. | 10 |
| SANOFI | 10 |
| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP3200591 | Sep 25, 2024 | Central Memory T Cells For Adoptive T Cell Therapy | CITY OF HOPE |
| EP3150699 | Aug 21, 2024 | Culture Medium Containing Uridine And N-Acetyl-D-Mannosamine | JCR PHARMACEUTICALS CO., LTD. |
| EP2734538 | Jul 3, 2024 | Method Of Reversibly Staining A Target Cell | IBA GMBH |
| EP3011037 | Jun 26, 2024 | Rhizomania-Resistant Gene | KWS SAAT SE |
| EP3296395 | Jun 19, 2024 | Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| EP2282764 | Jun 12, 2024 | Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof | LIFE SCIENCES RESEARCH PARTNERS VZW |
| EP2582794 | Apr 24, 2024 | Generation Of Induced Pluripotent Stem Cells From Small Volumes Of Peripheral Blood | CELLULAR DYNAMICS INTERNATIONAL, INC. |
| EP3911354 | Apr 3, 2024 | Aav-Mediated Gene Therapy Restoring The Otoferlin Gene | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) |
| EP3400291 | Feb 28, 2024 | Engineered Virus | REPLIMUNE LIMITED |
| EP2956477 | Jan 24, 2024 | Optimized Factor Viii Gene | BIOGEN MA INC. |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP3261651 | May 4, 2022 | Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof | MA, YUPO | 36 |
| EP1974014 | Apr 19, 2017 | Oligopeptide Free Cell Culture Media | BAXALTA GMBH | 24 |
| EP3444271 | Oct 6, 2021 | Il 15 And Il 15raplha Sushi Domain Based Modulokines | INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) | 24 |
| EP2791160 | Mar 2, 2022 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNA THERAPEUTICS, INC. | 20 |
| EP2664343 | Dec 18, 2019 | Suppression Of Cancer | SYNTAXIN LIMITED | 18 |
| EP3911354 | Apr 3, 2024 | Aav Mediated Gene Therapy Restoring The Otoferlin Gene | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) | 16 |
| EP3119423 | Dec 14, 2022 | Treatment Of Cancer Using Chimeric Antigen Receptor | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 12 |
| EP3445407 | Dec 14, 2022 | Compositions And Methods Of Cellular Immunotherapy | CARSGEN THERAPEUTICS CO., LTD. | 12 |
| EP2282764 | Jun 12, 2024 | Liver Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof | UNIVERSITEIT GENT | 12 |
| EP2419144 | Aug 7, 2019 | Composition For Delivery Of Genetic Material | ISIS INNOVATION LIMITED | 12 |
Feel free to send us a message here and we will get back to you